Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 3/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cloperastine SCHEMBL9613613 | 1.00 | SLC6A2 (1.00) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 | |
| Cloperastine SCHEMBL29617329 | 1.00 | SLC6A2 (1.00) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 | |
| Cloperastine SCHEMBL23733 | 0.99 | CYP3A4 (1.00) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 | |
| SCHEMBL1151981 | 0.99 | SLC6A2 (0.97) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 | |
| Cloperastine SCHEMBL1651228 | 0.97 | SLC6A2 (0.95) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 | |
| Perastine SCHEMBL1506306 | 0.91 | CYP3A4 (0.83) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 | |
| Perastine SCHEMBL29768269 | 0.90 | CYP3A4 (0.83) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 | |
| SCHEMBL9050633 | 0.86 | SIGMAR1 (0.84) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 | |
| Difencloxazine SCHEMBL29710921 | 0.86 | SLC6A2 (0.76) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 | |
| SCHEMBL17942915 | 0.86 | CYP3A4 (0.75) | SLC6A2SLC6A4SLC6A3CYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2145 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12550885-B2 | Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells | UNIVERSITY OF CINCINNATI (US) | 2026-02-17 | — | — | US | claimed |
| EP-4658278-A1 | SELECTIVE FIASMA TREATMENT | Valo Health, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| EP-4609859-A1 | INHIBITORS OF THE GENE SMPD1 FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY | Universidad Pablo de Olavide (ES) | 2025-09-03 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| US-20240373748-A1 | Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-11-07 | — | — | US | claimed |
| WO-2024163699-A1 | SELECTIVE FIASMA TREATMENT | VALO HEALTH, INC. (US) | 2024-08-08 | — | — | WO | claimed |
| US-20240226084-A9 | HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS | TECHFIELDS PHARMA CO., LTD. (CN) | 2024-07-11 | — | — | US | claimed |
| EP-1226831-A1 | Aqueous pharmaceutical solutions with trisubstituted glycyrrhizic acid salts | Baiocchi, Leandro (IT) | 2002-07-31 | — | — | EP | claimed |
| WO-2002055530-A2 | TRANSCOBALAMIN BINDING CONJUGATES USEFUL FOR TREATING ABNORMAL CELLULAR PROLIFERATION | MAYO FOUNDATION (US) | 2002-07-18 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0664118-B1 | SUSTAINED-RELEASE TABLET | YOSHITOMI PHARMACEUTICAL (JP) | 1999-08-25 | — | — | EP | claimed |
| CN-1043302-C | Group of drugs with antitussive and expectorant functions | ZHANG JUNYE (CN) | 1999-05-12 | — | — | CN | claimed |
| EP-0894794-A1 | Optical isomers of cloperastine | AESCULAPIUS FARMACEUTICI S.r.l. (IT) | 1999-02-03 | — | — | EP | claimed |
| EP-0582380-B1 | Dry granulation using a fluidized bed | MCNEIL PPC INC (US) | 1996-09-04 | — | — | EP | claimed |
| CN-1102567-A | Group of drugs with antitussive and expectorant functions | ZHANG JUNYE (CN) | 1995-05-17 | — | — | CN | claimed |
| EP-0385491-A1 | Optically active isomer of cloperastine possessing antitussive activity, a process for its preparation and pharmaceutical compositions which contain it | MAGIS FARMACEUTICI S.p.A. (IT) | 1990-09-05 | — | — | EP | claimed |